BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29630507)

  • 21. Prevalence and reproductive manifestations of macroprolactinemia.
    Kalsi AK; Halder A; Jain M; Chaturvedi PK; Sharma JB
    Endocrine; 2019 Feb; 63(2):332-340. PubMed ID: 30269265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum prolactin and macroprolactin levels in diabetic nephropathy.
    Sari F; Sari R; Ozdem S; Sarikaya M; Cetinkaya R
    Clin Nephrol; 2012 Jul; 78(1):33-9. PubMed ID: 22732335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antipsychotics-induced hyperprolactinemia and screening for macroprolactin.
    Ruljancic N; Bakliza A; Vuk Pisk S; Geres N; Matic K; Ivezic E; Grosic V; Filipcic I
    Biochem Med (Zagreb); 2021 Feb; 31(1):010707. PubMed ID: 33380894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment of reference intervals of monomeric prolactin to identify macroprolactinemia in Chinese patients with increased total prolactin.
    Hu Y; Ni J; Zhang B; Cheng W; Zhang H; Ye H; Ji L; Lu B; Guan M
    BMC Endocr Disord; 2021 Oct; 21(1):197. PubMed ID: 34620143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of PEG precipitation and ultrafiltration treatment for serum macroprolactin in Chinese patients with hyperprolactinemia.
    Ke X; Wang L; Duan L; Yang H; Yin J; Qiu L; Pan H; Gong F; Zhu H
    Clin Chim Acta; 2023 Apr; 544():117358. PubMed ID: 37086942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers.
    Hattori N; Ishihara T; Saiki Y
    Clin Endocrinol (Oxf); 2009 Nov; 71(5):702-8. PubMed ID: 19486017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macroprolactin: From laboratory to clinical practice.
    Biagetti B; Ferrer Costa R; Alfayate Guerra R; Álvarez García E; Berlanga Escalera E; Casals G; Esteban Salán M; Granada Ibern ML; Gorrín Ramos J; López Lazareno N; Oriola J; Sánchez Martínez PM; Torregrosa Quesada ME; Urgell Rull E; García Lacalle C
    Endocrinol Diabetes Nutr (Engl Ed); 2022 Jan; 69(1):63-69. PubMed ID: 35232561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macroprolactin: From laboratory to clinical practice.
    Biagetti B; Ferrer Costa R; Alfayate Guerra R; Álvarez García E; Berlanga Escalera E; Casals G; Esteban Salán M; Granada Ibern ML; Gorrín Ramos J; López Lazareno N; Oriola J; Sánchez Martínez PM; Torregrosa Quesada ME; Urgell Rull E; García Lacalle C
    Endocrinol Diabetes Nutr (Engl Ed); 2021 Apr; ():. PubMed ID: 33903089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macroprolactinemia in hyperprolactinemic infertile women.
    Thirunavakkarasu K; Dutta P; Sridhar S; Dhaliwal L; Prashad GR; Gainder S; Sachdeva N; Bhansali A
    Endocrine; 2013 Dec; 44(3):750-5. PubMed ID: 23543432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of prolactin: the macroprolactin problem.
    Fahie-Wilson M; Smith TP
    Best Pract Res Clin Endocrinol Metab; 2013 Oct; 27(5):725-42. PubMed ID: 24094642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A New Method of Using Polyethylene Glycol (PEG) Precipitation of Macroprolactin to Detect Genuine Hyperprolactinemia.
    Chen Y; Wang H; Yang W; Jin W; Yu W; Wang W; Zhang K; Song G
    J Clin Lab Anal; 2016 Nov; 30(6):1169-1174. PubMed ID: 27219457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macroprolactinemia in patients with hyperprolactinemia: an experience from a single tertiary center.
    Chutpiboonwat P; Yenpinyosuk K; Sridama V; Kunjan S; Klaimukh K; Snabboon T
    Pan Afr Med J; 2020; 36():8. PubMed ID: 32550971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolactin Assay Interference by Macroprolactin.
    Saparamadu AADNS; Lam CWL; Lim LC; Lee J
    Clin Lab; 2021 Jul; 67(7):. PubMed ID: 34258986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method.
    Leslie H; Courtney CH; Bell PM; Hadden DR; McCance DR; Ellis PK; Sheridan B; Atkinson AB
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2743-6. PubMed ID: 11397880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Roche Elecsys Prolactin II assay: reactivity with macroprolactin compared with eight commercial assays for prolactin and determination of monomeric prolactin by precipitation with polyethylene glycol.
    Fahie-Wilson M; Bieglmayer C; Kratzsch J; Nusbaumer C; Roth HJ; Zaninotto M; Plebani M; Hubbuch A; Schneider E
    Clin Lab; 2007; 53(5-6):301-7. PubMed ID: 17605405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laboratory and clinical significance of macroprolactinemia in women with hyperprolactinemia.
    Kasum M; Orešković S; Čehić E; Šunj M; Lila A; Ejubović E
    Taiwan J Obstet Gynecol; 2017 Dec; 56(6):719-724. PubMed ID: 29241908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. False-positive polyethylene glycol precipitation tests for macroprolactin due to increased serum globulins.
    Ram S; Harris B; Fernando JJ; Gama R; Fahie-Wilson M
    Ann Clin Biochem; 2008 May; 45(Pt 3):256-9. PubMed ID: 18482912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and radiological features of patients with macroprolactinaemia.
    Strachan MW; Teoh WL; Don-Wauchope AC; Seth J; Stoddart M; Beckett GJ
    Clin Endocrinol (Oxf); 2003 Sep; 59(3):339-46. PubMed ID: 12919157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The importance of measuring macroprolactin in the differential diagnosis of hyperprolactinemic patients.
    Lu CC; Hsieh CJ
    Kaohsiung J Med Sci; 2012 Feb; 28(2):94-9. PubMed ID: 22313536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macroprolactinemia in women with hyperprolactinemia: a 10-year follow-up.
    Radavelli-Bagatini S; Lhullier FL; Mallmann ES; Spritzer PM
    Neuro Endocrinol Lett; 2013; 34(3):207-11. PubMed ID: 23685418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.